The University of North Carolina Hospitals Investigational Drug Services — Chapel Hill, North Carolina

The University of North Carolina Hospitals Investigational Drug Services is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

The University of North Carolina Hospitals Investigational Drug Services has participated in 1 clinical trials.

Therapeutic areas: Lupus Erythematosus, Systemic.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of North Carolina Hospitals Investigational Drug Services?

The University of North Carolina Hospitals Investigational Drug Services has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of North Carolina Hospitals Investigational Drug Services conducted?

The University of North Carolina Hospitals Investigational Drug Services has 1 clinical trials on record. Their work covers Lupus Erythematosus, Systemic.

Is The University of North Carolina Hospitals Investigational Drug Services accredited by Crixeo Health?

The University of North Carolina Hospitals Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of North Carolina Hospitals Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.